Abstract:ID 93611 Poster Board 502 Methamphetamine abuse amongst adolescents has been on the rise in the United States. Exposure to methamphetamine followed by withdrawal can lead to sensitization of brain circuits, which can promote continued abuse of methamphetamine. However, neural substrates underlying methamphetamine-induced sensitization in adolescents has not been fully explored. In this study, we focused on the behavioral effects of methamphetamine in male and female adolescent rats with a history of methamphetamine exposure and kappa opioid receptors (KOR) manipulation. Adolescent male and female rats (approx. 4 weeks of age) were used in the study, which was conducted over 28 days. All animals were treated with saline on Day 1 to assess baseline locomotor activity and to habituate the animals to the locomotor activity chambers. Methamphetamine (0.5 mg/kg; i.p.) induced locomotor activity (primary dependent measure) was measured on Days 2 and 28 in all animals irrespective of treatment between Days 3-8 (period of intermittent repeated methamphetamine exposure). After assessment of methamphetamine-induced locomotor activity on Day 2, male and female adolescent rats were divided into three groups: Group one animals received an injection saline (1 ml/kg; s.c.; control) 30 minutes prior to treatment with methamphetamine (1 mg/kg; i,p,) daily for 6 days (Days 3-8); Group two animals received an injection of the KOR agonist (U50488; 6 mg/kg; s.c.) 30 minutes prior to treatment with methamphetamine (1 mg/kg; i,p,) daily for 6 days (Days 3-8); Group 3 animals received the KOR antagonist (norBNI; 15 mg/kg; s.c.) on Day 2 approximately four hours after measurement of methamphetamine (0.5 mg/kg; i.p.)-induced locomotor activity. Subsequently, all Group 3 animals were treated with an injection of methamphetamine (1 mg/kg; i,p,) daily for 6 days (Days 3-8). Animals received only one injection of the KOR antagonist (norBNI) because of its long duration of action. Animals received no methamphetamine treatment between Days 9-27 (drug-free/ withdrawal period). This drug-free period has been hypothesized to alter brain circuits resulting in sensitized responses to methamphetamine. Blockade of the KORs prior to methamphetamine (1 mg/kg) exposure (Days 3-8; Group 3) significantly increased methamphetamine-induced locomotor activity [measured as percentage of baseline (Day 2)] in adolescent male rats, but not female rats, compared to respective saline controls (Group 1). However, there was no significant difference in methamphetamine-induced locomotor activity on Day 28 [measured as percentage of baseline (Day 2)] in either male or female adolescent rats treated with the KOR agonist during methamphetamine (1 mg/kg) exposure (Days 3-8; Group 2) compared to respective saline controls (Group 1). Based on the data we can suggest an underlying inhibitory role of the KORs on methamphetamine-induced locomotor activity in adolescent male rats, which was unmasked by blocking KORs prior to methamphetamine (1 mg/kg) exposure. Previously, we had reported similar effects of blockade of the KORs on methamphetamine-induced locomotor activity in adult male, but not female, rats. Together, the data suggest a sex-dependent differential role for the KORs on methamphetamine-induced locomotor activity in adolescent male and female rats with a history of methamphetamine exposure and KOR manipulation. Supported by Endowed Pharmacy Centennial Research Award, Raabe College of Pharmacy and Ohio Northern University

Prelimbic Cortex Dynorphin/κ Opioid Receptor System Modulates Methamphetamine‐induced Cognitive Impairment

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

Neuronal activation of nucleus accumbens by local methamphetamine administration induces cognitive impairment through microglial inflammation in mice

The Role Of Dopamine D1 And D3 Receptors In N-Methyl-D-Aspartate (Nmda)/Glycine(B) Site-Regulated Complex Cognitive Behaviors Following Repeated Morphine Administration

The neuroprotective effect of LCZ696 on methamphetamine-induced cognitive impairment in mice

The effect of the NLRP1 inflammasome on methamphetamine-induced cognitive impairment in rats

Single-dose methamphetamine administration impairs ORM retrieval in mice via excessive DA-mediated inhibition of PrL Glu activity

Methamphetamine-induced impairment of memory and fleeting neuroinflammation: Profiling mRNA changes in mouse hippocampus following short-term and long-term exposure

Neuroprotective effect of histamine H3 receptor blockade on methamphetamine-induced cognitive impairment in mice

Naloxone reversed cognitive impairments induced by repeated morphine under heavy perceptual load in the 5-choice serial reaction time task.

The Roles of K+-dependent Na+/Ca2+ Exchanger 2 (NCKX2) in Methamphetamine-Induced Behavioral Sensitization and Conditioned Place Preference in Mice.

The Distinct Roles of Various Neurotransmitters in Modulating Methamphetamine-Induced Conditioned Place Preference in Relevant Brain Regions in Mice

PPARγ/Adiponectin axis attenuates methamphetamine-induced conditional place preference via the hippocampal AdipoR1 signaling pathway

The modulation of cholecystokinin receptor 1 in the NAc core input from VTA on METH-induced CPP acquisition

Dysregulated kappa-opioid receptors in the medial prefrontal cortex contribute to working memory deficits in alcohol dependence

Distinct Roles of Methamphetamine in Modulating Spatial Memory Consolidation, Retrieval, Reconsolidation and the Accompanying Changes of ERK and CREB Activation in Hippocampus and Prefrontal Cortex

p-Nrf2/HO-1 Pathway Involved in Methamphetamine-induced Executive Dysfunction through Endoplasmic Reticulum Stress and Apoptosis in the Dorsal Striatum

Reversal of Cocaine-Conditioned Place Preference Through Methyl Supplementation in Mice: Altering Global Dna Methylation in the Prefrontal Cortex

The role of orexin receptors within the CA1 area in the acquisition and expression of methamphetamine place preference

Differential sex-dependent behavioral effects of methamphetamine in adolescent rats with a history of methamphetamine exposure and kappa opioid receptor manipulation

Methamphetamine Exacerbates Neuroinflammatory Response to Lipopolysaccharide by Activating Dopamine D1-like Receptors